Veterinary Medicines

Selevitan vet. 30mg/g + 0,6mg/g rakeet

Authorised
  • Sodium selenite
  • ALPHATOCOPHEROL ACETATE
Download as PDF

Product identification

Medicine name:
Selevitan vet. 30mg/g + 0,6mg/g rakeet
Active substance:
  • Sodium selenite
  • ALPHATOCOPHEROL ACETATE
Target species:
  • Pig
  • Sheep
  • Cattle
  • Horse
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Sodium selenite
    0.60
    milligram(s)
    /
    1.00
    gram(s)
  • ALPHATOCOPHEROL ACETATE
    30.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Granules
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        0
        day
    • Sheep
      • Meat and offal
        0
        day
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12CE99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Pharmaxim AB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Orkla Care A/S
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 7897
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 11/04/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 11/04/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."